Tissue Factor and Platelet Glycoprotein Ib-α Alleles Are Associated with Age at First Coronary Bypass Operation

Anesthesiology

Volumn 99, Issue 6, 2003, Pages 1287-1294

  Donahue, Brian S ^a,b   Byrne, Daniel W ^a   Gailani, David ^a   George Jr , Alfred L ^a  

^a Department of Anesthesiology ^*

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN IB; PLATELET GLYCOPROTEIN IB ALPHA; THROMBOPLASTIN; UNCLASSIFIED DRUG;

ADULT; AGE; ALLELE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC POLYMORPHISM; HEART SURGERY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; SEX DIFFERENCE; SMOKING; TANDEM REPEAT;

ADULT; AGE FACTORS; AGED; ALLELES; CORONARY ARTERY BYPASS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MINISATELLITE REPEATS; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; THROMBOPLASTIN;

EID: 0345714939     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200312000-00009     Document Type: Article

References (50)

1. Hogue CW Jr, Sundt T III, Barzilai B, Schecthman KB, Davila-Roman VG: Cardiac and neurologic complications identify risks for mortality for both men and women undergoing coronary artery bypass graft surgery. ANESTHESIOLOGY 2001; 95:1074-8
2. Hogue CW Jr, De Wet CJ, Schechtman KB, Davila-Roman VG: The importance of prior stroke for the adjusted risk of neurologic injury after cardiac surgery for women and men. ANESTHESIOLOGY 2003; 98:823-9
3. Newman MF, Kramer D, Croughwell ND, Sanderson I, Blumenthal JA, White WD, Smith LR, Towner EA, Reves JG: Differential age effects of mean arterial pressure and rewarming on cognitive dysfunction after cardiac surgery. Anesth Analg 1995; 81:236-42
4. Newman MF, Grocott HP, Mathew JP, White WD, Landolfo K, Reves JG, Laskowitz DT, Mark DB, Blumenthal JA: Report of the substudy assessing the impact of neurocognitive function on quality of life 5 years after cardiac surgery. Stroke 2001; 32:2874-81
5. Provenchere S, Plantefeve G, Hufnagel G, Vicaut E, De Vaumas C, Lecharny JB, Depoix JP, Vrtovsnik F, Desmonts JM, Philip I: Renal dysfunction after cardiac surgery with nonnothermic cardiopulmonary bypass: Incidence, risk factors, and effect on clinical outcome. Anesth Analg 2003; 96:1258-64
6. Adams DC, Heyer EJ, Simon AE, Delphin E, Rose EA, Oz MC, McMahon DJ, Sun LS: Incidence of atrial fibrillation after mild or moderate hypothermic cardiopulmonary bypass. Crit Care Med 2000; 28:309-11
7. Amar D, Roistacher N, Zhang H, Baum MS, Ginsburg I, Steinberg JS: Signal-averaged P-wave duration does not predict atrial fibrillation after thoracic surgery. ANESTHESIOLOGY 1999; 91:16-23
8. Ducceschi V, D'Andrea A, Galderisi M, De Feo M, Limongelli G, Mercurio B, Sarubbi B, Caso P, Cerasuolo F, Cotrufo M: Risk predictors of paroxysmal atrial fibrillation following aortic valve replacement. Ital Heart J 2001; 2:507-12
9. Zacharias A, Schwann TA, Parenteau GL, Riordan CJ, Durham SJ, Engoren M, Fenn-Buderer N, Habib RH: Predictors of gastrointestinal complications in cardiac surgery. Tex Heart Inst J 2000; 27:93-9
10. Magovern JA, Sakert T, Benckart DH, Burkholder JA, Liebler GA, Magovern GJ Sr, Magovern GJ Jr: A model for predicting transfusion after coronary artery bypass grafting. Ann Thorac Surg 1996; 61:27-32
11. Wilcox JN, Smith KM, Schwartz SM, Gordon D: Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A 1989; 86:2839-43
12. Camerer E, Kolsto AB, Prydz H: Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb Res 1996; 81:1-41
13. Clemetson KJ: Platelet GPIb-V-IX complex. Thromb Haemost 1997; 78:266-70
14. Arnaud E, Barbalat V, Nicaud V, Camblen F, Evans A, Morrison C, Arveiler D, Luc G, Ruidavets JB, Emmerich J, Fiessinger JN, Aiach M: Polymorphisms in the 5′ regulatory region of the tissue factor gene and the risk of myocardial infarction and venous thromboembolism: The ECTIM and PATHROS studies. Etude Cas-Temoins de l'Infarctus du Myocarde. Paris Thrombosis case-control Study Arterioscler Thromb Vasc Biol 2000; 20:892-8
15. Kunicki TJ: The influence of platelet collagen receptor polymorphisms in hemostasis and thrombotic disease. Arterioscler Thromb Vasc Biol 2002; 22:14-20
16. Gonzalez-Conejero R, Lozano ML, Rivera J, Corral J, Iniesta JA, Moraleda JM, Vicente V: Polymorphisms of platelet membrane glycoprotein Ib associated with arterial thrombotic disease. Blood 1998; 92:2771-6
17. Murata M, Kawano K, Matsubara Y, Ishikawa K, Watanabe K, Ikeda Y: Genetic polymorphisms and risk of coronary artery disease. Semin Thromb Hemost 1998; 24:245-50
18. Mikkelsson J, Perola M, Penttila A, Karhunen PJ: Platelet glycoprotein Ibα HPA-2 Met/VNTR B haplotype as a genetic predictor of myocardial infarction and sudden cardiac death. Circulation 2001; 104:876-80
19. Kaiser R, Tremblay PB, Roots I, Brockmoller J: Validity of PCR with emphasis on variable number of tandem repeat analysis. Clin Biochem 2002; 35:49-56
20. Carter AM, Catto AJ, Bamford JM, Grant PJ: Platelet GP IIIa PIA and GP Ib variable number tandem repeat polymorphisms and markers of platelet activation in acute stroke. Arterioscler Thromb Vasc Biol 1998; 18:1124-31
21. Baker PI, Eikelboom J, Lofthouse E, Staples N, Afshar-Kharghan V, Lopez JA, Shen Y, Berndt MC, Hankey G: Platelet glycoprotein Ibα Kozak polymorphism is associated with an increased risk of ischemic stroke. Blood 2001; 98:36-40
22. Newman MF, Laskowitz DT, White WD, Kirchner JL, Grocott HP, Stafford-Smith M, Sketch MH, Jones RH, Reves JG, Saunders AM: Apolipoprotein E polymorphisms and age at first coronary artery bypass graft. Anesth Analg 2001; 92:824-9
23. Cooper JA, Miller GJ, Bauer KA, Morrissey JH, Meade TW, Howarth DJ, Barzegar S, Mitchell JP, Rosenberg RD: Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease. Circulation 2000; 102:2816-22
24. Daley GQ, Cargill M: The heart SNPs a beat: Polymorphisms in candidate genes for cardiovascular disease. Trends Cardiovasc Med 2001; 11:60-6
25. Nemerson Y: Tissue factor and hemostasis [published correction appears in Blood 1988; 71:1178]. Blood 1988; 71:1-8
26. Nemerson Y: Tissue factor and hemostasis [published correction appears in Blood 1988; 71:1178]. Blood 1988; 71:1-8
27. Ruf W, Edgington TS: Structural biology of tissue factor, the initiator of thrombogenesis in vivo. FASEB J 1994; 8:385-90
28. Samad F, Pandey M, Loskutoff DJ: Regulation of tissue factor gene expression in obesity. Blood 2001; 98:3353-8
29. Rivers RP, Cattermole HE, Wright I: The expression of surface tissue factor apoprotein by blood monocytes in the course of infections in early infancy. Pediatr Res 1992; 31:567-73
30. Amengual O, Atsumi T, Khamashta MA, Hughes GR: The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospolipid syndrome. Thromb Haemost 1998; 79:276-81
31. Reverter JC, Tassies D, Font J, Monteagudo J, Escolar G, Ingelmo M, Ordinas A: Hypercoagulable state in patients with antiphospholipid syndrome is related to high induced tissue factor expression on monocytes and to low free proteins. Arterioscler Thromb Vasc Biol 1996; 16:1319-26
32. Nygaard OP, Unneberg K, Relkeras O, Osterud B: Thromboplastin activity of blood monocytes after total hip replacement. Scand J Clin Lab Invest 1990; 50:183-6
33. Khajuria A, Houston DS: Induction of monocyte tissue factor expression by homocysteine: A possible mechanism for thrombosis. Blood 2000; 96:966-72
34. Ardissino D, Merlini PA, Ariens R, Coppola R, Bramucci E, Mannucci PM: Tissue-factor antigen and activity in human coronary atherosclerotic plaques. Lancet 1997; 349:769-71
35. Annex BH, Denning SM, Channon KM, Sketch MH Jr, Stack RS, Morrissey JH, Peters KG: Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation 1995; 91:619-22
36. Ardissino D, Merlini PA, Bauer KA, Bramucci E, Ferrario M, Coppola R, Fetiveau R, Lucreziotti S, Rosenberg RD, Mannucci PM: Thrombogenic potential of human coronary atherosclerotic plaques. Blood 2001; 98:2726-9
37. Versteeg HH, Peppelenbosch MP, Spek CA: The pleiotropic effects of tissue factor: A possible role for factor VIIa-induced intracellular signalling? Thromb Haemost 2001; 86:1353-9
38. Meiklejohn DJ, Vickers MA, Morrison ER, Dijkhuisen R, Moore I, Urbaniak SJ, Greaves M: In vivo platelet activation in atherothrombotic stroke is not determined by polymorphisms of human platelet glycoprotein IIIa or Ib. Br J Haematol 2001; 112:621-31
39. Ishida F, Ito T, Takei M, Shimodaira S, Kitano K, Kiyosawa K: Genetic linkage of Kozak sequence polymorphism of the platelet glycoprotein Ib alpha with human platelet antigen-2 and variable number of tandem repeats polymorphism, and its relationship with coronary artery disease. Br J Haematol 2000; 111:1247-9
40. Carlsson LE, Greinacher A, Spitzer C, Walther R, Kessler C: Polymorphisms of the human platelet antigens HPA-1, HPA-2, HPA-3, and HPA-5 on the platelet receptors for fibrinogen (GPIIb/IIIa), von Willebrand factor (GPIb/IX), and collagen (GPIa/IIa) are not correlated with an increased risk for stroke. Stroke 1997; 28:1392-5
41. Li CQ, Garner SF, Davies J, Smethurst PA, Wardell MR, Ouwehand WH: Threonine-145/methionine-145 variants of baculovirus produced recombinant ligand binding domain of GPIbα express HPA-2 epitopes and show equal binding of von Willebrand factor. Blood 2000; 95:205-11
42. Afshar-Kharghan V, Li CQ, Khoshnevis-Asl M, Lopez JA: Kozak sequence polymorphism of the glycoprotein (GP) Ibα gene is a major determinant of the plasma membrane levels of the platelet GP Ib-IX-V complex. Blood 1999; 94:186-91
43. Santoso S, Zimmermann P, Sachs UJ, Gardemann A: The impact of the Kozak sequence polymorphism of the glycoprotein Ib alpha gene on the risk and extent of coronary heart disease. Thromb Haemost 2002; 87:345-6
44. Douglas H, Michaelides K, Gorog DA, Durante-Mangoni E, Ahmed N, Davies GJ, Tuddenham EG: Platelet membrane glycoprotein Ibα gene-5T/C Kozak sequence polymorphism as an independent risk factor for the occurrence of coronary thrombosis. Heart 2002; 87:70-4
45. Kenny D, Muckian C, Fitzgerald DJ, Cannon CP, Shields DC: Platelet glycoprotein Ibα receptor polymorphisms and recurrent ischaemic events in acute coronary syndrome patients. J Thromb Thrombolysis 2002; 13:13-9
46. Frank MB, Reiner AP, Schwartz SM, Kumar PN, Pearce RM, Arbogast PG, Longstreth WT Jr, Rosendaal FR, Psaty BM, Siscovick DS: The Kozak sequence polymorphism of platelet glycoprotein Ibα and risk of nonfatal myocardial infarction and nonfatal stroke in young women. Blood 2001; 97:875-9
47. Croft SA, Hampton KK, Daly ME, Steeds RP, Channer KS, Samani NJ: Kozak sequence polymorphism in the platelet GPIbα gene is not associated with risk of myocardial infarction. Blood 2000; 95:2183-4
48. Cadroy Y, Sakariassen KS, Charlet JP, Thalamas C, Boneu B, Sie P: Role of 4 platelet membrane glycoprotein polymorphisms on experimental arterial thrombus formation in men. Blood 2001; 98:3159-61
49. Hamdan AD, Saltzberg SS, Sheahan M, Froelich J, Akbari CM, Campbell DR, LoGerfo FW, Pomposelli FB Jr: Lack of association of diabetes with increased postoperative mortality and cardiac morbidity: Results of 6565 major vascular operations. Arch Surg 2002; 137:417-21
50. Akbari CM, Pulling MC, Pomposelli FB Jr, Gibbons GW, Campbell DR, Logerfo FW: Gender and carotid endarterectomy: Does it matter? J Vasc Surg 2000; 31:1103-8